Research
Hormonal
Weight loss effectively reduces proinflammatory markers and hormones associated with increased risk of endometrioid EC.
Reducing weight can lower the risk factors for endometrial cancer in obese individuals.
StrongSupportsmedium confidence
Weight loss effectively reduces proinflammatory markers and hormones associated with increased risk of endometrioid EC.
Why this rating
Based on systematic review and meta-analysis.
Source
Effects of Weight Loss on Key Obesity-Related Biomarkers Linked to the Risk of Endometrial Cancer: A Systematic Review and Meta-Analysis
Angela D. Clontz et al. · Cancers · 2024
DOI 10.3390/cancers16122197
Meta-analysisCited 18×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →